All Type of News
Government to back innovative pharmaceutical firms
The government is under careful screening process to innovative pharmaceutical firms to offer a total of 146 billion won in subsidies, the Ministry of Health and Welfare said Tuesday.
In a local workshop organized ...
Korean drug makers shy of M&As
The government plans to ease regulations to promote the development of innovative medicine and medical treatments, as well as encourage mergers and acquisitions (M&As) among pharmaceutical firms in order to make them ...
Dong-A’s top 19 flagship products account for 68% in 2011 sales
Dong-A Pharmaceutical Co. said recently that it garnered 68 percent of its sales from 19 leading drugs last year.
The combined sales of the 19 flagship drugs stood at 620.8 billion won from the company’s gross reve...
Local drug makers to file individual suit against government
An individual action lawsuit opposing the government’s price-cut plan is expected to be filed in the middle of next month at the latest, the Korea Pharmaceutical Manufacturers Association said.
The government plans...
Retail drug prices to fall 14% on average in April
Insurance-covered drug prices are expected to fall about 14 percent on average beginning April following a set of government-led reforms, the government said Monday.
The Ministry of Health and Welfare Monday announ...
National Assembly unable to agree on bill to permit supermarket drug sales
The plenary session of parliament Monday adjourned with no agreement on how to deal with a bill to permit the sale of certain drugs at local supermarkets and convenient stores that could make it easier for people to b...
Government to boost SK Biopharm’s epilepsy drug development
The government has recently unveiled its plan to support SK Biopharmaceuticals’ new epilepsy drug as part of its efforts to nurture blockbuster drugs, targeting the international market.
The company has since 2006 ...
Battle gets fiercer over impotence drug market
Local drug makers are expected to wage fiercer campaigns to raise their impotence drug market share as the patent of an impotence medicine Viagra t is due to expire in May 17.
The domestic market for erectile dysfu...
KPMA urged to come up with countermeasures over price-cut plan and KORUS FTA
The new executives of the Korea Pharmaceutical Manufacturers Association needs to assess the damage that the government’s impending price-cut plan and Korea’s free trade deals with the U.S. would cause in the pharmace...
OECD warns Korea’s hefty health care spending
Korea’s healthcare system depends too much on hospitals to treat the illness and not enough on community-based medical practices to keep people healthy, according to a report of Organization for Economic Cooperation a...
